BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21474708)

  • 1. Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.
    Muñoz A; Chen JG; Egner PA; Marshall ML; Johnson JL; Schneider MF; Lu JH; Zhu YR; Wang JB; Chen TY; Kensler TW; Groopman JD
    Carcinogenesis; 2011 Jun; 32(6):860-5. PubMed ID: 21474708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration to death from liver cancer in people with hepatitis B viral mutations detected in plasma by mass spectrometry.
    Chen JG; Kuang SY; Egner PA; Lu JH; Zhu YR; Wang JB; Zhang BC; Chen TY; Muñoz A; Kensler TW; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1213-8. PubMed ID: 17548687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific mutations of hepatitis B virus in plasma predict liver cancer development.
    Kuang SY; Jackson PE; Wang JB; Lu PX; Muñoz A; Qian GS; Kensler TW; Groopman JD
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3575-80. PubMed ID: 14990795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort.
    Chao LT; Wu CF; Sung FY; Lin CL; Liu CJ; Huang CJ; Tsai KS; Yu MW
    Carcinogenesis; 2011 Jun; 32(6):876-81. PubMed ID: 21464041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.
    Chu CM; Lin CC; Lin SM; Lin DY; Liaw YF
    Dig Dis Sci; 2012 Jan; 57(1):232-8. PubMed ID: 21837473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.
    Qu LS; Liu JX; Liu TT; Shen XZ; Chen TY; Ni ZP; Lu CH
    PLoS One; 2014; 9(5):e98257. PubMed ID: 24849936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China.
    Qu L; Kuai X; Liu T; Chen T; Ni Z; Shen X
    PLoS One; 2013; 8(3):e59583. PubMed ID: 23555717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk features of HBV in human hepatocarcinogenesis: a nested case-controlled study].
    Zhang F; Shao YF; Gao JD; Xu Y; Liu GT; Xu LB; Wu ZY; Gao WH; Sun ZT
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1482-4. PubMed ID: 18275715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of hepatitis B virus isolated from Black South African cancer patients, with and without hepatocellular carcinoma.
    Mak D; Kramvis A
    Arch Virol; 2020 Aug; 165(8):1815-1825. PubMed ID: 32504396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
    Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma.
    Wu Y; Gan Y; Gao F; Zhao Z; Jin Y; Zhu Y; Sun Z; Wu H; Chen T; Wang J; Sun Y; Fan C; Xiang Y; Qian G; Groopman JD; Gu J; Tu H
    PLoS One; 2014; 9(5):e94864. PubMed ID: 24788140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China.
    Yuan JM; Ambinder A; Fan Y; Gao YT; Yu MC; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):590-4. PubMed ID: 19190166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher prevalence of cancer related mutations 1762T/1764A and PreS deletions in hepatitis B virus (HBV) isolated from HBV/HIV co-infected compared to HBV-mono-infected Chinese adults.
    Li KW; Kramvis A; Liang S; He X; Chen QY; Wang C; Yang QL; Hu LP; Jia HH; Fang ZL
    Virus Res; 2017 Jan; 227():88-95. PubMed ID: 27720823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China.
    Liu TT; Fang Y; Xiong H; Chen TY; Ni ZP; Luo JF; Zhao NQ; Shen XZ
    World J Gastroenterol; 2008 May; 14(19):3059-63. PubMed ID: 18494059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
    Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
    Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
    Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc.
    Oon CJ; Chen WN; Goh KT; Mesenas S; Ng HS; Chiang G; Tan C; Koh S; Teng SW; Toh I; Moh MC; Goo KS; Tan K; Leong AL; Tan GS
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S491-6. PubMed ID: 12534784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
    Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
    J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.